A detailed history of State Of Tennessee, Treasury Department transactions in Abbott Laboratories stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 623,795 shares of ABT stock, worth $71.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
623,795
Previous 679,916 8.25%
Holding current value
$71.3 Million
Previous $70.7 Million 0.66%
% of portfolio
0.26%
Previous 0.26%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $5.62 Million - $6.63 Million
-56,121 Reduced 8.25%
623,795 $71.1 Million
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $3.41 Million - $3.8 Million
-33,815 Reduced 4.74%
679,916 $70.7 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $4.16 Million - $4.59 Million
-37,965 Reduced 5.05%
713,731 $81.1 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $17.3 Million - $21.2 Million
191,755 Added 34.25%
751,696 $82.7 Million
Q2 2023

Aug 15, 2023

BUY
$100.78 - $112.29 $20.1 Million - $22.4 Million
199,564 Added 55.38%
559,941 $61 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $19.1 Million - $22.5 Million
-197,420 Reduced 35.39%
360,377 $36.5 Million
Q4 2022

Feb 15, 2023

SELL
$95.06 - $111.52 $5.56 Million - $6.52 Million
-58,440 Reduced 9.48%
557,797 $61.2 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $10.7 Million - $13 Million
105,234 Added 20.59%
616,237 $67 Million
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $26.3 Million - $32.1 Million
-231,059 Reduced 31.14%
511,003 $60.5 Million
Q4 2021

Feb 15, 2022

SELL
$115.53 - $141.46 $41.9 Million - $51.3 Million
-362,756 Reduced 32.83%
742,062 $104 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $3.88 Million - $4.29 Million
33,235 Added 3.1%
1,104,818 $131 Million
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $18.3 Million - $21.5 Million
172,838 Added 19.23%
1,071,583 $124 Million
Q1 2021

May 10, 2021

SELL
$108.84 - $128.23 $13.7 Million - $16.1 Million
-125,533 Reduced 12.26%
898,745 $108 Million
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $50.9 Million - $55.5 Million
485,042 Added 89.95%
1,024,278 $112 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $66 Million - $80.1 Million
-719,808 Reduced 57.17%
539,236 $58.7 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $52.3 Million - $66.9 Million
682,581 Added 118.41%
1,259,044 $115 Million
Q1 2020

May 28, 2020

BUY
$62.82 - $91.86 $36.2 Million - $53 Million
576,463 New
576,463 $45.5 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $64.1 Million - $93.7 Million
-1,020,487 Closed
0 $0
Q4 2019

Feb 06, 2020

SELL
$78.51 - $87.4 $5.62 Million - $6.26 Million
-71,596 Reduced 6.56%
1,020,487 $88.6 Million
Q3 2019

Oct 30, 2019

BUY
$81.84 - $88.74 $35.8 Million - $38.8 Million
437,035 Added 66.72%
1,092,083 $91.4 Million
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $3.7 Million - $4.32 Million
-50,818 Reduced 7.2%
655,048 $55.1 Million
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $77.9 Million - $94.2 Million
-1,176,057 Reduced 62.49%
705,866 $56.4 Million
Q4 2018

Feb 11, 2019

BUY
$65.56 - $74.27 $13.1 Million - $14.8 Million
199,318 Added 11.85%
1,881,923 $136 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $9.05 Million - $10.9 Million
148,803 Added 9.7%
1,682,605 $123 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $22.8 Million - $25.2 Million
396,618 Added 34.88%
1,533,802 $93.5 Million
Q1 2018

May 11, 2018

BUY
$56.27 - $63.62 $15.9 Million - $18 Million
282,220 Added 33.01%
1,137,184 $68.1 Million
Q4 2017

Feb 12, 2018

SELL
$53.68 - $57.47 $20 Million - $21.5 Million
-373,428 Reduced 30.4%
854,964 $48.8 Million
Q3 2017

Nov 01, 2017

BUY
$48.06 - $53.64 $59 Million - $65.9 Million
1,228,392
1,228,392 $65.5 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track State Of Tennessee, Treasury Department Portfolio

Follow State Of Tennessee, Treasury Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.